Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2020
Nexplanon recommended after second submission
22 October 2020 - The first submission was withdrawn. ...
Posted by Michael Wonder on 22 Oct 2020
Will HIRA resume talk to grant benefits for anti-diabetic combo drugs?
22 October 2020 - Three makers of SGLT-2 inhibiting anti-diabetic drugs said they would seek changes in approval conditions to ...
Posted by Michael Wonder on 22 Oct 2020
CADTH in favour of new indication for Soliris
22 October 2020 - CADTH has finalised its assessment of eculizumab for adult patients with refractory generalised myasthenia gravis. ...
Posted by Michael Wonder on 21 Oct 2020
NICE in favour of another highly specialised technology
21 October 2020 - Familial chylomicronaemia syndrome is a rare and potentially life-threatening condition that has a significant effect on the ...
Posted by Michael Wonder on 21 Oct 2020
ICER posts draft scoping document for the assessment of Alzheimer’s disease
21 October 2020 - Document open to public comment until 10 November 2020. ...
Posted by Michael Wonder on 21 Oct 2020
NICE recommended use of Opdivo for another indication
20 October 2020 - This marks the tenth NICE recommendation for nivolumab. ...
Posted by Michael Wonder on 21 Oct 2020
California plans to review coronavirus vaccine independently
19 October 2020 - California is planning to review federally approved coronavirus vaccines independently before distributing it to residents, Governor ...
Posted by Michael Wonder on 20 Oct 2020
Welcome to the new PHARMAC.govt.nz
20 October 2020 - PHARMAC has upgraded the technology underlying its website. ...
Posted by Michael Wonder on 18 Oct 2020
PBAC recommends Zeposia for patients with relapsing-remitting multiple sclerosis
16 October 2020 - Did Celgene really request its use for the treatment of non-premenopausal patients with hormone receptor positive, ...
Posted by Michael Wonder on 18 Oct 2020
Highlights from 12-15 October CHMP meeting
16 October 2020 - Ten new medicines recommended for approval. ...
Posted by Michael Wonder on 18 Oct 2020
ICER publishes final report and policy recommendations for targeted immune modulator therapies for ulcerative colitis
16 October 2020 - Independent appraisal committee votes that evidence is adequate to demonstrate clinical superiority of vedolizumab over adalimumab. ...
Posted by Michael Wonder on 18 Oct 2020
Community engagement in health technology assessment and beyond: from guests in the process to hosts
15 October 2020 - In health technology assessment, clinical and economic evidence are assessed in the regulatory and reimbursement environments, with ...
Posted by Michael Wonder on 17 Oct 2020
ICER publishes evidence report on therapies for haemophilia A
16 October 2020 - Emicizumab assessed as providing comparable or better clinical benefits when compared to common current dosing levels of ...
Posted by Michael Wonder on 16 Oct 2020
NICE gears up to support world evidence-based health care day
16 October 2020 - Inaugural World Evidence-based Health care Day takes place on Tuesday 20 October 2020. ...
Posted by Michael Wonder on 16 Oct 2020
Recommendations made by the PBAC - September 2020 intracycle meeting and out of session between July 2020 and September 2020 meetings
16 October 2020 - The recommendations from the September 2020 PBAC intracycle meeting are now available. ...